Skip to content
Subscriber Only

The U.S. Is Facing an EpiPen Shortage

  • More than 400 patients in 45 states report device hard to find
  • Mylan says it’s in contact with FDA, which has reported no gap
Bloomberg business news
EpiPen shortages
Updated on

Adults and children with severe allergies are experiencing problems finding EpiPens after issues with manufacturing of the lifesaving devices, according to patients and pharmacists.

More than 400 patients in 45 states have reported difficulty filling prescriptions for Mylan NV’s allergy devices and other auto-injectors containing the active ingredient epinephrine since May 2, James Baker, chief executive officer of patient-advocacy group Food Allergy Research & Education, said in an interview.